NDC 10956-333 Preferred Maximum Strength Urinary Pain Relief
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 10956 - Reese Pharmaceutical Co
- 10956-333 - Preferred Maximum Strength Urinary Pain Relief
Product Characteristics
Product Packages
NDC Code 10956-333-12
Package Description: 1 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
NDC Code 10956-333-24
Package Description: 2 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
Product Details
What is NDC 10956-333?
What are the uses for Preferred Maximum Strength Urinary Pain Relief?
Which are Preferred Maximum Strength Urinary Pain Relief UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17)
- PHENAZOPYRIDINE (UNII: K2J09EMJ52) (Active Moiety)
Which are Preferred Maximum Strength Urinary Pain Relief Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE (UNII: J2B2A4N98G)
- MAGNESIUM SILICATE (UNII: 9B9691B2N9)
What is the NDC to RxNorm Crosswalk for Preferred Maximum Strength Urinary Pain Relief?
- RxCUI: 1094357 - phenazopyridine HCl 97.5 MG Oral Tablet
- RxCUI: 1094357 - phenazopyridine hydrochloride 97.5 MG Oral Tablet
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".